Skip to main content
Chelsea Pinnix, MD, Radiation Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

ChelseaCPinnixMDPhD

Radiation Oncology Houston, TX

Associate Professor, Residency Program Director

Dr. Pinnix is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pinnix's full profile

Already have an account?

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2008 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 2007 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2007

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2022 - 2023
  • GA State Medical License
    GA State Medical License 2022 - 2024
  • MS State Medical License
    MS State Medical License 2022 - 2023
  • TN State Medical License
    TN State Medical License 2022 - 2025
  • FL State Medical License
    FL State Medical License 2021 - Present
  • OK State Medical License
    OK State Medical License 2020 - 2023
  • TX State Medical License
    TX State Medical License 2010 - 2024
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • Assessment of Radiation Doses Delivered to Organs at Risk Among Patients with Early-Stage Favorable Hodgkin Lymphoma Treated with Contemporary Radiation Therapy  
    Chelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, Jason Westin, Simrit Parmar, Loretta Nastoupil, Sattva Neelapu, Bouthaina S Dabaja, JAMA Network Open

Abstracts/Posters

  • Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma
    Chelsea Camille Pinnix, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Radiotherapy Patients Can Safely Use Lotions for Irritated Skin
    Radiotherapy Patients Can Safely Use Lotions for Irritated SkinNovember 1st, 2018
  • No 'Sound Science' Behind Avoiding Topical Agents Before RT
    No 'Sound Science' Behind Avoiding Topical Agents Before RTOctober 18th, 2018
  • “Mentoring to Medicine” Presents Professional Possibilities to Students of Color
    “Mentoring to Medicine” Presents Professional Possibilities to Students of ColorOctober 30th, 2018
  • Join now to see all

Hospital Affiliations